Hongping Jin

3PUBLICATIONS
7CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 15, 2026
PD-L1 expression is associated with inferior outcomes independent of EGFR subtype in advanced non-small cell lung cancer with uncommon EGFR mutations treated with first-line second-generation EGFR-tyrosine kinase inhibitors.

|Feb 04, 2026
Efficacy of first-line immunochemotherapy across KRAS mutation subtypes in advanced lung adenocarcinoma.

Hongping Jin, Honglei Huang, Yiqing Wu

|Apr 25, 2025
Comparison of first-generation EGFR-TKIs combined with low-dose bevacizumab versus osimertinib in untreated advanced EGFR-mutated NSCLC.

Yingqi Xu, Yidan Zhang, Hongping Jin

Pageof 1

Frequent Collaborators

3 joint publications

Runbo Zhong

1 joint publications

Yingqi Xu

1 joint publications

Yidan Zhang

1 joint publications

Yuqing Lou